Why the study?
Does captopril decrease alpha(1)-adrenoceptor expression and function in the aorta of pre-hypertensive rats?
Does captopril decrease alpha(1)-adrenoceptor expression and function in the aorta of pre-hypertensive rats?
ACE inhibition with captopril reduces alpha(1D)-adrenoceptor expression and function in the aorta of pre-hypertensive rats, suggesting a mechanism for its vascular effects.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ACEI vascular mechanisms in hypertensive models; leaves open human translation and should not change practice.
1.-- The effects of captopril on alpha(1)-adrenoceptor mRNA and protein and phenylephrine-induced contraction was assessed in aorta of pre-hypertensive spontaneously hypertensive rats. 2.-- Four-week-old SHR and WKY rats were treated with captopril [an angiotensin-converting enzyme (ACE) inhibitor] 3 mg kg(-1) day(-1) for 1 week. 3.-- pA(2) values for BMY 7378, an alpha(1D)-adrenoceptor antagonist, were 8.63-9.20 among the different groups. Schild slopes were close to unity suggesting that contraction was produced primarily by alpha(1D)-adrenoceptor stimulation and was not changed with therapy. 4.-- Alpha(1D)-adrenoceptor mRNA and protein values were higher in pre-hypertensive SHR than in WKY, whereas alpha(1A)-adrenoceptor mRNA was higher in WKY and alpha(1B)-adrenoceptors were similar in both strains, and protein was not significantly different for alpha(1A)- and alpha(1B)-subtypes. 5.-- Captopril decreased maximal contraction in SHR, without having effect in WKY rats, while alpha(1D)-adrenoceptor mRNA was decreased in both rat strains but alpha(1D)-adrenoceptor protein was significantly decreased only in SHR, and increased alpha(1A)-mRNA in SHR, no effect of captopril treatment was observed on alpha(1B)-adrenoceptor mRNA and protein nor on alpha(1A)-adrenoceptor protein. 6.-- These data suggest that ACE inhibition by captopril influences both expression and function of alpha(1D)-adrenoceptors in aorta of pre-hypertensive rats, probably avoiding alpha(1D)-subtype expression by blockade of angiotensin II synthesis.
No takes yet. Share an insight, caveat, or question.
Godínez‐Hernández et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: